These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 25596269)

  • 1. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.
    Origa R; Cazzola M; Mereu E; Danjou F; Barella S; Giagu N; Galanello R; Swinkels DW
    Haematologica; 2015 May; 100(5):e169-71. PubMed ID: 25596269
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait.
    Jones E; Pasricha SR; Allen A; Evans P; Fisher CA; Wray K; Premawardhena A; Bandara D; Perera A; Webster C; Sturges P; Olivieri NF; St Pierre T; Armitage AE; Porter JB; Weatherall DJ; Drakesmith H
    Blood; 2015 Jan; 125(5):873-80. PubMed ID: 25519750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
    Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
    Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepcidin independent iron recycling in a mouse model of β-thalassaemia intermedia.
    Frazer DM; Wilkins SJ; Mirciov CS; Dunn LA; Anderson GJ
    Br J Haematol; 2016 Oct; 175(2):308-317. PubMed ID: 27410488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Glycosylation Profiles of Serum Glycoprotein from Iron Overload Thalassemia.
    Huang A; Huang C; Zhang M; Zhu X; Qin X
    Clin Lab; 2018 Jul; 64(7):1279-1287. PubMed ID: 30146840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron Status in Newly Diagnosed
    Susanah S; Rakhmilla LE; Ghozali M; Trisaputra JO; Moestopo O; Sribudiani Y; Idjradinata PS; Maskoen AM
    Biomed Res Int; 2021; 2021():5560319. PubMed ID: 33954177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
    Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
    Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of hepcidin as therapy for primary and secondary iron overload disorders: preclinical models and approaches.
    Schmidt PJ; Fleming MD
    Hematol Oncol Clin North Am; 2014 Apr; 28(2):387-401. PubMed ID: 24589273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of erythropoiesis and iron metabolism in patients with thalassemia.
    Huang Y; Lei Y; Liu R; Liu J; Yang G; Xiang Z; Liang Y; Lai Y
    Int J Med Sci; 2019; 16(2):302-310. PubMed ID: 30745811
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.
    Frazer DM; Wilkins SJ; Darshan D; Badrick AC; McLaren GD; Anderson GJ
    Br J Haematol; 2012 Jun; 157(5):615-26. PubMed ID: 22449175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
    Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
    Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
    Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
    J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Porter JB; Cappellini MD; Kattamis A; Viprakasit V; Musallam KM; Zhu Z; Taher AT
    Br J Haematol; 2017 Jan; 176(2):288-299. PubMed ID: 27917462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.
    Pasricha SR; Frazer DM; Bowden DK; Anderson GJ
    Blood; 2013 Jul; 122(1):124-33. PubMed ID: 23656728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current management of thalassemia intermedia].
    Thuret I
    Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.
    Ginzburg Y; Rivella S
    Blood; 2011 Oct; 118(16):4321-30. PubMed ID: 21768301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of erythroferrone as an erythroid regulator of iron metabolism.
    Kautz L; Jung G; Valore EV; Rivella S; Nemeth E; Ganz T
    Nat Genet; 2014 Jul; 46(7):678-84. PubMed ID: 24880340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.
    Gardenghi S; Marongiu MF; Ramos P; Guy E; Breda L; Chadburn A; Liu Y; Amariglio N; Rechavi G; Rachmilewitz EA; Breuer W; Cabantchik ZI; Wrighting DM; Andrews NC; de Sousa M; Giardina PJ; Grady RW; Rivella S
    Blood; 2007 Jun; 109(11):5027-35. PubMed ID: 17299088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.